|
MRPL50 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.8460013779561E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.391200E-04 |
| Normal-vs-Stage2 |
1.118370E-02 |
| Normal-vs-Stage3 |
<1E-12 |
| Normal-vs-Stage4 |
1.24390497902027E-11 |
| Stage1-vs-Stage2 |
4.678400E-01 |
| Stage1-vs-Stage3 |
9.48900003017172E-09 |
| Stage1-vs-Stage4 |
5.50149999999361E-05 |
| Stage2-vs-Stage3 |
2.274500E-02 |
| Stage2-vs-Stage4 |
4.821800E-02 |
| Stage3-vs-Stage4 |
7.579200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.77160533307597E-11 |
| Normal-vs-AfricanAmerican |
2.775900E-03 |
| Normal-vs-Asian |
1.101470E-03 |
| Caucasian-vs-AfricanAmerican |
4.755200E-01 |
| Caucasian-vs-Asian |
6.416200E-01 |
| AfricanAmerican-vs-Asian |
4.733400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.77555756156289E-15 |
| Normal-vs-Female |
1.056270E-02 |
| Male-vs-Female |
3.08059999998278E-06 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.676190E-03 |
| Normal-vs-Age(41-60Yrs) |
1.67389999972123E-07 |
| Normal-vs-Age(61-80Yrs) |
7.90579823828352E-11 |
| Normal-vs-Age(81-100Yrs) |
1.826190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.565800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.860000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.001400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.929400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.710600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.562800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.484000E-01 |
| Normal-vs-Grade 2 |
1.895180E-03 |
| Normal-vs-Grade 3 |
2.62034838272029E-12 |
| Normal-vs-Grade 4 |
1.62447832963153E-12 |
| Grade 1-vs-Grade 2 |
2.243400E-01 |
| Grade 1-vs-Grade 3 |
1.313730E-02 |
| Grade 1-vs-Grade 4 |
1.81966999999172E-05 |
| Grade 2-vs-Grade 3 |
8.05010000000106E-05 |
| Grade 2-vs-Grade 4 |
6.10490547003906E-11 |
| Grade 3-vs-Grade 4 |
4.211500E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.871600E-01 |
| Normal-vs-ccB subtype |
1.62447832963153E-12 |
| ccA subtype-vs-ccB subtype |
2.55351295663786E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.95700000438626E-08 |
| Normal-vs-N1 |
2.98119995356672E-09 |
| N0-vs-N1 |
2.971500E-02 |
|
|
